Jean-Michel Sallenave Ph.D.
Professor of Immunology, INSERM U1152, HÃ´pital Bichat, Paris, France
Pr J-M Sallenave obtained his PhD (on Immunology of gestation) in Bordeaux, France. After a post-doctoral period in Edinburgh (Scotland, UK), where he worked on the role of the protease/antiprotease balance in lung mucosal inflammation, he moved to Pr J. Gauldie's lab (McMaster University, Hamilton, Canada) where he used gene transfer techniques to promote lung protection in inflammatory murine models (1992-1996). He then joined the MRC Center for Inflammation (Edinburgh, Scotland) as a PI (1996-2006) where his team worked on the role of antimicrobial molecules in Pseudomonas aeruginosa lung infection models. In 2006, he joined the Pasteur Institute (Paris, France, 2006-2014), as a PI and Professor of Immunology, working on TLR5-Pseudomonas and Influenza-proteases signalling pathways and the deleterious role of neutrophil host proteases in cystic fibrosis. In 2014, he moved to the INSERM U 1152 (HÃ´pital Bichat, Paris, France), where his team is working on deciphering the protective role of host endogenous antimicrobials and nanoparticles in lung inflammation in cystic fibrosis and other lung pathologies. He has served on several advisory boards of learned societies. For example, he has participated recently in the organization of the Â« Lung Science Conferences Â» (European Respiratory Society) from 2013 to 2016 as co-'Program coordinator', and is currently a member of the organizing committe of this program (Estoril, Portugal). In addition, he is member of the ICPC (International Congress Programme Committee group), responsible for over-seeing the scientific program of the ERS at the annual congress.